ReviewJournal of thoracic disease2025
Lung cancer in young individuals; risk factors and epidemiology.
Review in Journal of thoracic disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Nanocarrier-Based Drug Delivery Systems for Lung Cancer: A Systematic Review and Meta-Analysis of Preclinical Studies.Advances in respiratory medicine · 2026Pooled it
- Trajectories of pulmonary subsolid nodules in children and adolescents: a retrospective multicenter cohort study.European radiology · 2026Article
- Clinicopathological Characteristics, Molecular Findings, and Survival of Lung Cancer in Adults Aged <30 Years in China: A Retrospective Cohort Study.Journal of clinical medicine · 2026Article
- Physical activity, functional capacity, and mental health during the first postoperative month in patients undergoing ambulatory pulmonary wedge resection: a prospective observational study.BMC pulmonary medicine · 2026Observational
- Surgical outcomes of lung cancer associated with autoimmune disease-related interstitial pneumonia.General thoracic and cardiovascular surgery · 2026Article
- Patient profiles, incidence and trends of lung cancer in Ethiopia from 2012 to 2023 using a cancer registry.Scientific reports · 2026Article
- Age-related differences in clinical characteristics and survival in lung cancer.Frontiers in oncology · 2026Article
- Surgical Resection for Rare Cases of Lung Cancer in Teenagers.Respirology case reports · 2025Article
- Temporal Trends and Patient Stratification in Lung Cancer: A Comprehensive Clustering Analysis from Timis County, Romania.Cancers · 2025Article
- Intratumoral microbiota: synergistic reshaping of lung cancer microenvironment via inflammation and immunity.Frontiers in immunology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lung cancer remains a leading cause of cancer-related deaths globally, with an estimated 2.5 million new patients and 1.8 million deaths in 2022. While lung cancer predominantly affects older individuals, there is growing concern about the impact of lung cancer on younger generations, specifically adolescents and young adults (AYA) patients aged 15-39 years. Lung cancer in young individuals has several unique characteristics, such as sex preference, histological subtype, and frequency of somatic mutations in
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.